Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis

Heart

Volumn 88, Issue 3, 2002, Pages 260-265

  Hsu, L F ^a   Mak, Koon Hou ^a   Lau, K W ^a   Sim, L L ^a   Chan, C ^a   Koh, T H ^a   Chuah, S C ^a   Kam, R ^a   Ding, Z P ^a   Teo, W S ^a   Lim, Y L ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; INSULIN; STREPTOKINASE; THIENO[2,3 B]PYRIDINE DERIVATIVE; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; FUNCTIONAL ASSESSMENT; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; ONSET AGE; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; STENT; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036720891     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.3.260     Document Type: Article

References (34)

1. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience
2. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
3. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients
4. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
5. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
6. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
7. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review
8. Long-term outcome after primary angioplasty: Report from the primary angioplasty in myocardial infarction (PAMI-I) trial
9. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
10. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy
11. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction
12. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: Results of the GUSTO ST segment monitoring study
13. Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients
14. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients
15. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
16. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence randomized elective stenting in acute coronary occlusion (FRESCO) trial
17. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
18. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial. Primary angioplasty in myocardial infarction stent pilot trial investigators
19. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: The primary angioplasty in myocardial infarction (PAMI) stent pilot trial
20. Primary stenting in acute myocardial infarction: Influence of diabetes mellitus in angiographic results and clinical outcome
21. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: Evidence for a complex interaction in a multicenter trial
22. Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of platelet IIb/IIIa Inhibition in stenting investigators
23. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus. Results of the EPISTENT (evaluation of platelet IIb/IIIa inhibition in stenting trial) diabetic substudy
24. Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation
25. Acute myocardial infarction: Are diabetics different?
26. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
27. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction: Final results from the primary angioplasty registry
28. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression. Immediate and long-term results of a randomized study
29. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction
30. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
31. Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link
32. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction
33. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
34. One-year results from the global utilization of streptokinase and TPA for occluded coronary arteries (GUSTO-I) trial